Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/337364
Type: Artigo
Title: Safety, tolerability, and effects of sodium bicarbonate inhalation in cystic fibrosis
Author: Souza Gomez, Carla Cristina
Francisco Parazzi, Paloma Lopes
Clinckspoor, Karl Jan
Mauch, Renan Marrichi
Teixeira Pessine, Francisco Benedito
Levy, Carlos Emilio
Peixoto, Andressa Oliveira
Goncalves Oliveira Ribeiro, Maria Angela
Ribeiro, Antonio Fernando
Conrad, Douglas
Quinton, Paul Marquis
Lima Marson, Fernando Augusto
Ribeiro, Jose Dirceu
Abstract: Among the many consequences of loss of CFTR protein function, a significant reduction of the secretion of bicarbonate (HCO3-) in cystic fibrosis (CF) is a major pathogenic feature. Loss of HCO3- leads to abnormally low pH and impaired mucus clearance in airways and other exocrine organs, which suggests that NaHCO3 inhalation may be a low-cost, easily accessible therapy for CF. Objective To evaluate the safety, tolerability, and effects of inhaled aerosols of NaHCO3 solutions (4.2% and 8.4%). Methods An experimental, prospective, open-label, pilot, clinical study was conducted with 12 CF volunteer participants over 18 years of age with bronchiectasis and pulmonary functions classified as mildly to severely depressed. Sputum rheology, pH, and microbiology were examined as well as spirometry, exercise performance, quality-of-life assessments, dyspnea, blood count, and venous blood gas levels. Results Sputum pH increased immediately after inhalation of NaHCO3 at each clinical visit and was inversely correlated with rheology when all parameters were evaluated: [G ' (elasticity of the mucus) = - 0.241; G '' (viscosity of the mucus) = - 0.287; G* (viscoelasticity of the mucus) = - 0.275]. G* and G ' were slightly correlated with peak flow, forced expiratory volume in 1 s (FEV1), and quality of life; G '' was correlated with quality of life; sputum pH was correlated with oxygen consumption (VO2) and vitality score in quality of life. No changes were observed in blood count, venous blood gas, respiratory rate, heart rate, peripheral oxygen saturation of hemoglobin (SpO(2)), body temperature, or incidence of dyspnea. No adverse events associated with the study were observed. Conclusion Nebulized NaHCO3 inhalation appears to be a safe and well tolerated potential therapeutic agent in the management of CF. Nebulized NaHCO3 inhalation temporarily elevates airway liquid pH and reduces sputum viscosity and viscoelasticity.
Subject: Fibrose cística
Bicarbonato de sódio
Country: Nova Zelândia
Editor: Springer
Rights: Fechado
Identifier DOI: 10.1007/s40261-019-00861-x
Address: https://link.springer.com/article/10.1007%2Fs40261-019-00861-x
Date Issue: 2019
Appears in Collections:IQ - Artigos e Outros Documentos
FCM - Artigos e Outros Documentos

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.